Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Company Profile
Latest Presentation
Industry Classifications
Sector:
Biotechnology
Industry:
Drug Development
NAICS:
Research and Development in the Physical, Engineering, and Life Sciences (541710)
SIC:
Commercial Physical and Biological Research (8731)
Contact Information
Investor Relations
Christopher Moreau
Chief Executive Officer
T: 604-398-4175
chris@algernonpharmaceuticals.com
Transfer Agent
TSX Trust Company
1066 W. Hastings Street
Suite 1600
Vancouver, BC V6E 3X1
Canada
T: 604-235-3700
inquiries@astfinancial.com
Company Contact
Algernon Pharmaceuticals Inc.
601 West Broadway
Suite 400
Vancouver, BC V5Z 4C2
Canada
T: 604-398-4175
info@algernonpharmaceuticals.com